News | Published: Monday, October 24, 2016 4:30 am
Disease-based programs grew in momentum in the 1990s as a tool to improve care for patients with chronic disease while identifying and reducing high-cost and low-value care events. Usually, disease-based programs are focused on how to keep people healthy and out of the hospital; it may not always be “top of mind” to think about disease programs as a means of program growth and stability. It is helpful to understand the basic goals of a chronic disease program in order to connect the potential impact on program growth and clinical benefits.
Chronic disease programs develop by identifying the following measures:
There are many disease-based programs currently operating; in order to highlight the link between a disease-based program and new program growth, this article focuses on heart failure. Heart failure disease programs have been an early focus for cardiology due to value-based readmission penalties and rewards. Although other disease-based programs were developed, heart failure was unique in that the financial impact of reducing high-cost readmissions was a proven result. It could be argued that even without the prompting of value-based purchasing, the heart failure patient population was a prime candidate for disease management due to the high volume, high cost, and variation in treatment that existed. For many, it seems intuitive that a heart failure disease-based program would be a critical part of population health management. But how does a disease program affect growth, and potentially, cardiovascular procedures?
Learn how by reading the full article here: